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Propolis or bee glue is an important natural bee product that has been used by humans to meet the needs of health since 
ancient times. Despite its many valuable uses, scientific research on propolis is still limited. Despite rich traditional 
zootherapeutic knowledge of the people and affluent biodiversity of North-east India, almost no research study has been 
undertaken on the assessment of various biological properties of propolis from this region. Recently, the antibacterial and 
antitumor activity of the methanolic extract of propolis (MeOH-propolis) from Meghalaya was reported by us only. The 
present study was undertaken to further examine the antitumor activity and toxicity in ascites Dalton’s Lymphoma bearing 
mice itself and compare with that of cisplatin, a well established anticancer drug also known to cause different toxicities in 
the host. MeOH-propolis showed potent anticancer activity against ascites Dalton’s lymphoma. The assessment of various 
toxicity parameters such as hematotoxicity, nephrotoxicity, hepatotoxicity and sperm abnormality revealed that 
MeOH-propolis treatment did not develop any toxicity while cisplatin developed these toxicities in the host. It is suggested 
that the increasing antioxidative defense activity of the MeOH-propolis could be involved in its ability to avoid any toxicity 
in the host. The findings from the present study showing the combined action of MeOH-propolis as anticancer as well as its 
ability to stabilize various toxicity parameters in cancer-bearing mice suggest the possibility of using propolis as a natural 
alternative to chemotherapy to shun the side effects. 
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Introduction 
Cancer is the second leading cause of death 
globally and is responsible for an estimated 9.6 
million deaths in 2018
1
. Chemotherapy has proved to 
be an effective treatment that can be used either singly 
or in combination with surgery and/or radiotherapy 
against various types of cancers. However, the 
efficacy of most of the anticancer drugs is often 
hampered by the development of various side effects
2
 
and acquired resistance by cancer cells
3
. Therefore, 
in an attempt to overcome the side effects of 
chemotherapeutic drugs while maintaining therapeutic 
efficacy, the primary focus of the researchers has also 




Animals or animal products have been used in the 
treatment of various diseases including cancer
6,7
. 
Honeybees, a social insect, belong to the order- 
Hymenoptera and family-Apidae
8
. From honeybees, 
seven amazing products, i.e., bee pollen, bee wax, 
royal jelly, honey, mead, bee bread, and propolis have 
been identified which have proved to be useful to 
humankind and treating with honeybee products is 
called apitherapy
9
. Out of these products, propolis is 
of vital importance for the survival of the honey bees 
in the beehive and also to people. Etymologically, the 
Greek word propolis means a pro, for or in defence, 
and polis, the city, that is ―defence of the city 
(beehive)
10
. Propolis, also known as ‘bee glue’ is the 
lipophilic, brownish-coloured sticky natural substance 
of beehive which is used as a sealant and sterilant in 
and around the beehive
11
. Honeybees collect resinous 
sticky material with their hind legs from leaf buds, 
twigs and trunk wounds of various plants, mix it with 
salivary secretions and wax in the beehive colony to 
form propolis
12,13
. Today propolis is widely used in 
medicine, cosmetics, and food industries due to its 
versatile biological and pharmacological activities 
such as antibacterial, anticarcinogenic, antiviral, 
immunomodulatory, anticancer, anti-inflammatory 
and antidiabetic properties
11,14,15








effects of propolis, caffeic acid phenethyl ester 
(CAPE) and chrysin in cancer cells are the result of 
the suppression of complexes of cyclins, as well as 
cell cycle arrest, induction of apoptosis pathways
16
 












 properties of 
propolis have been reported. The composition and 
constituents of propolis vary depending on the 
geographical vegetation, climate, honey bee species 
as well as by the collecting season
11,22
. Very often the 
name of propolis is based on the place and country of 















Meghalaya is one of the eight states of  
North-east India, known for its clouds and the  
highest rainfall in the world. It comprises 11 districts  
and the population is predominantly tribal  
which mainly includes Khasis, Garos, and Jaintias 
who have their respective dialect, distinct ways of 
life, belief, traditions, and cultural heritage
26
. In the 
present study, the propolis was collected from 
Ngunraw village of Meghalaya, so it is being referred 
here as Meghalaya propolis. Ngunraw village is 
approximately 135 Km away from Shillong, situated 
between 25°17'52.5" N latitude and 91°19'23.2" E 
longitude located under Mawkyrwat block of  
South West Khasi Hills district, Meghalaya. 
Agriculture and apiculture are the main sources  
of livelihood of the people and the Indian  
hive-bee, Apis cerana indica (Apidae) is the common 
honey bee species reared in this area. 
There is almost no study undertaken on the 
assessment of the biological properties of propolis 
from North-east India. Given a variety of reports on 
the properties of propolis from different parts of the 
world, the antibacterial and antitumor potential of 
propolis from Meghalaya was studied for the first 
time by us
27
. Very often the assessment of the toxicity 
of an anticancer drug is studied by the treatment  
of normal animals which does not give the real 
circumstances because it is the tumor-bearing 
animals, not the normal animals, which are treated 
with these drugs. Therefore, the present study  
was undertaken to look at the effect of this propolis 
extract on the antitumor activity and toxicity 
concerning histopathology of liver and kidney,  
and haematological parameters in the same  
Dalton’s lymphoma tumor-bearing mice. Cisplatin 
(cis-diamminedichloroplatinum-II), a well established 
anticancer drug also known to cause different toxicities, 
was used as the reference drug for a comparative 
elucidation of the propolis-mediated findings. 
 
Materials and Methods 
 
Chemical 
Reduced glutathione (GSH), 5, 5 N-dithiobis-2-
nitrobenzoic acids (DTNB), 1-chloro-2,4-
dinitrobenzene (CDNB), and bovine serum albumin 
(BSA) were purchased from Sigma Chemical Co., St. 
Louis, Mo, USA. Ethylenediamine tetra-acetic acid 
(EDTA), and other chemicals used in the experiments 
were of analytical grade and purchased from SRL Pvt. 
Ltd., Mumbai, India. Cisplatin solution (1 mg per mL 
of 0.9%, NaCl) was obtained from Biochem 
Pharmaceutical Industries, Mumbai. 
 
Animal and tumor maintenance 
Swiss albino mice colony is being maintained 
under conventional laboratory conditions at room 
temperature of 22±2 °C keeping 5-6 animals per 
propylene cage using paddy husk as a bed with food 
pellets (Amrut Laboratory animal feeds, New Delhi) 
and drinking water ad libitum. Inbred Swiss albino 
mice of both sexes in the age group of about  
10-12 weeks weighing about 28-30 g were used  
for the experiments. Dalton’s lymphoma is a 
transplantable and highly invasive T cell lymphoma 
that develops an ascitic tumor in murines
28
. Ascites 
Dalton’s lymphoma has been widely used by the 
researchers for evaluating the anticancer potentials of 
a variety of drugs. Dalton’s lymphoma (DL) is being 
maintained in vivo in mice of both sexes by serial 
intraperitoneal (i.p.) transplantation of approximately 
1x10
7
 viable tumor cells per animal (0.25 mL in 
phosphate-buffered saline (PBS), pH 7.4). Tumor 
transplanted hosts usually survive for 19-21 days. The 
maintenance, use of the animals and the experimental 
protocol of the present study have been approved with 
reference number IEC/NEHU/December 04/2014 by 
the Institutional ethics committee (animal models), 
North-Eastern Hill University, Shillong, India  
 
Propolis collection and preparation of methanolic extract  
Beehives maintained in an apiary at Ngunraw 
village, South West Khasi Hills district of Meghalaya, 
India were collected during spring and winter seasons. 
It was cleaned, freed from wax and raw propolis was 
separated. Its methanolic extract (MeOH-propolis) 
was prepared as per the details described earlier
27
. 




Drug treatment and antitumor activity  





 treatment of tumor-
bearing mice was selected. Tumor-transplanted mice 
were randomly divided into three groups consisting of 
10 mice in each group and the day of tumor 
transplantation was taken as day zero. Group-I mice 
served as tumor-bearing control and received extract 
vehicle only. Group-II mice were administered  
with methanol extract of propolis (MeOH-propolis) 
(i.p., 50 mg/kg body weight) for 5 consecutive days 
starting from the 6
th
 day post-tumor transplantation. 
Group-III mice were administered with the reference 
drug, cisplatin (i.p., 2 mg/kg body weight/ day.) for 




The death of animals, if any, and body weights of 
animals in different groups were recorded daily. The 
antitumor efficacy was reported in percentage of the 
average increase in life span (% ILS) calculated using 
the formula: 
Percentage Increase in life span =  
MST  of  treated  group −MST  of  control  grou p
MST  of  control  group
 ×100 
Where MST (Mean survival time) =  
Σ survival time (days) of each mice in a group
Total number of mice
 





day post tumor transplantation, the animals were 
sacrificed by cervical dislocation, tissues and blood 
were collected, and used for some biochemical, 
histological and haematological investigation. For 
comparative analysis, haematological study was also 
done on blood from normal mice i.e., mice without 
tumor and any treatment.  
 
Viability of DL cells and splenocytes  
Trypan blue exclusion assay was carried out to 
check the viability of DL cells and splenocytes 
collected from the mice under different treatment 
conditions
30
. It is based on the principle that viable 
cells possess intact cell membranes that exclude 
trypan blue, whereas dead cells do not. Therefore, all 
the viable cells will have a clear cytoplasm whereas a 
nonviable cell will have a blue cytoplasm. Dalton’s 
lymphoma ascites and spleen were collected from  
the mice in different groups at 96 h of treatment.  
The ascites tumor was centrifuged gently (800 × g, 10 
min at 4 
o
C). The cell pellets were resuspended in 
PBS to get uniform cell suspension. The spleen was 
minced into small pieces with a scissor, squeezed 
between two microscopical slides and the detached 
cells were drained gently in PBS to get the single-cell 
suspension. To lyse the erythrocytes, an equal volume 
of 0.85% NH4Cl was added to the cell suspension, 
mixed gently and incubated at room temperature for 
3-4 minutes. After centrifugation (400×g at 4 °C for 
10 min), the pelleted cells were resuspended in PBS 
to get the single-cell suspension of splenocytes which 
were used to determine viability. To the cell 
suspension, an equal volume of 0.4% trypan blue  
dye (4 mg/100 mL PBS) was added and incubated  
at room temperature for 4-5 min with intermittent 
gentle shaking. After 5 minutes, cell suspension  
was taken on a hemocytometer and counted under a 
light microscope. The percentage of dead cells i.e., 
cytotoxicity was calculated by dividing the number of 
dead cells by the number of total cells and multiplying 
by one hundred. 
 
Reduced glutathione (GSH) estimation  
Total reduced glutathione (GSH) in liver, kidney 
and DL cells was determined using the method of 
Sedlak and Lindsay
31
. Briefly, 5% tissue homogenates 
of DL cells, kidney, or liver were prepared in 0.02 M 
EDTA (pH 4.7). Total GSH was determined by 
adding the tissue homogenate or pure reduced form of 
glutathione (100 μL) to 0.9 mL of 0.02 mol/L EDTA, 
pH 4.7 and 1 mL of 0.2 mol/L Tris–EDTA buffer, pH 
8.2, and followed by 20 μL of Ellman’s reagent  
(10 mmol/L DTNB in methanol). After 30 minutes of 
incubation at room temperature, the reaction mixture 
was centrifuged at 3000 x g and the absorbance of the 
clear supernatant was read against a reagent blank at 
412 nm in a Varian Carey-50 spectrophotometer. The 
results were read from a standard curve prepared from 
1mmol/L solution of reduced glutathione. 
 
Evaluation of hematological parameters 
The blood for haematological studies was collected 
from the eye orbit using the capillary tube from the 
mice in different experimental groups into a sterilized 
tube containing anticoagulant heparin (15-20 IU per 
mL of blood) and used for the haematological study. 
The haemoglobin content, red blood cells (RBC) 
counts, white blood cells (WBC) counts, and packed 
cell volume (PCV) were determined according to the 




Haemoglobin (Hb) estimation  
Freshly collected blood was diluted (200 times) 
with cyanide-ferricyanide reagent (200 mg potassium 
ferricyanide and 50 mg potassium cyanide in 1 litre  




of distilled water, pH 9.6) and allowed to stand for  
10 min at room temperature. The absorbance was read 
at 540 nm in a spectrophotometer. The haemoglobin 
content was calculated as follows: 
Hb concentration (g/dL) = A540 × 64500 × dilution 
factor /44.0 × d × 1000 × 10 
where, A540
 
= absorbance at 540 nm, 64500= 
molecular weight of Hb, dilution factor= 200,  
44.0= millimolar extinction coefficient, d= layer 
thickness (cm), 1000= conversion factor for mg  
to g, 10= conversion factor for g/L to g/dL. 
 
Red blood cells (RBCs) counts 
Freshly collected blood was diluted (200 times) 
with RBC diluting fluid. The diluted blood sample 
was filled in a Neubauer counting chamber with its 
cover-glass already in position and the RBC counting 
was done and calculated as follows: 
RBC count per µL = N × 1 x 200 (dilution)/ 0.02 






White blood cells (WBCs) counts 
Freshly collected blood was diluted (20 times) with 
white blood cells (WBC) diluting fluid (2% acetic 
acid) contained in a plastic tube. The diluted blood 
sample was mixed for about 1 minute and counted in 
a Neubauer chamber. The number of white blood cell 
was calculated as follows: 
WBC count per µL = N × 10 x20 (dilution) = N × 200 
= N × 200 x10
6
 / L 
 
Packed cell volume (PCV) determination 
Blood was collected in a wintrobe tube and 
centrifuged for 30 min (2000 x g, at 4 ºC). The height 
of the column of red cells was taken as the PCV  
(the volume occupied by the red blood cells expressed 
as a fraction of the total volume of the blood). 
 
Differential leucocytes counts 
Differential leucocytes count was carried out 
according to Swarup et al.
33
. A drop of fresh blood 
was taken on a clean slide and a thin and uniform 
blood film was prepared with the help of another 
clean slide. The blood film was air-dried for 
overnight, stained with Leishman’s stain the 
following day and mounted in DPX. Counting was 
done under the microscope in a narrow longitudinal 
strip of the blood film starting from one end of the 
film to the other end. The number of different types  
of white blood cells (neutrophils, basophils, 
monocytes, lymphocytes, and eosinophils) was  
noted and expressed in percentage. 
Scanning electron microscopy (SEM) study for the abnormality 
in RBCs  
A small drop of freshly collected blood was taken in a 
clean micro centrifuged tube and fixed in 2.5% 
glutaraldehyde for 30 min at room temperature. After 
fixation, the blood was centrifuged for 5 min at 750 × g 
at 4 °C. The pellet was washed twice in phosphate buffer 
and re-suspended in distilled water. A thin film of 
suspension was made on a clean coverslip and allowed 
to air dry. The coverslip was mounted on a brass  
stub with double-stick tape, coated with gold in a fine 
coat ionic sputter (SCD-005, BAL-TEC Co.). The red 
blood cells (RBCs) were thoroughly examined for 
abnormalities in RBCs under an electron microscope 
(JEOL JSM-6360, SEM) and photographed. 
 
Histopathological study 
The liver and kidney were collected from the mice 
in different experimental groups after 7 days of the 
last treatment and fixed in Bouin’s fixative until  
used. The tissues were washed with tap water and 
processed for dehydration in progressively increasing 
concentrations of ethanol (30, 50, 70, 90, and 100%), 
cleared in xylene, infiltrated by liquid paraffin and 
cooled to form a solid paraffin block containing the 
tissues. Paraffin-tissue sections (5-6 µm in thickness) 
were cut with a microtome (Sipcon) and mounted on 
clean glass slides which had been smeared with a drop 
of Mayer’s albumin. It was then spread on a hot  
plate at about 50 ºC for 2-3 minutes. The sections 
were dehydrated and stained with hematoxylin-eosin, 
cleared in xylene and mounted with cover glass, 
examined and photographed under an optical 
microscope DMRX (Leica 650) to assess different 
structural features in the tissue.  
 
Sperm abnormality assay 
The male mice in different groups were sacrificed on 
the 10
th
 day of treatment. The cauda epididymis was 
removed and placed in physiological saline. It was then 
minced into pieces and kept undisturbed for 20 minutes. 
The sperms were spread on a clean slide, fixed in 
absolute methanol for 15 minutes and then stained with 
1% aqueous eosin-Y on the following day. Five hundred 
sperms from the mouse in each group were examined 
for the abnormalities in sperm head and tail shapes 
following the criteria as close as possible to those 





The results were expressed as mean ± S.D. The data 
were statistically analyzed using one-way analysis of 




variance (ANOVA) with Tukey’s multiple comparison 
post hoc tests to compare the level of significance 
between control and experimental groups. A P-value 




Viability of DL cells and splenocytes 
Trypan blue exclusion test for the cell viability 
showed that MeOH-propolis, as well as cisplatin 
treatment, caused a significant decrease in the viability 
of DL cells. However, splenocytes’ viability was not 
affected by MeOH-propolis treatment (Fig. 1).  
 
Antitumor activity 
Following DL tumor transplantation, the increase 
in belly size with the sluggish movement of the 
animals was noted from the 3-4
th 
day onwards 
showing an early sign of tumor development. Control 
tumor-bearing mice showed a gradual increase in 
body weight until death while MeOH-propolis or 
cisplatin treatment significantly prevented the 
increase in body weight due to tumor growth  
(Fig. 2). The tumor-bearing mice treated with  
MeOH-propolis (Group-II) or cisplatin (Group-III) 
showed the average increase in life span (% ILS) of 
about 97% and 133% respectively (Table 1). 
 
Reduced glutathione (GSH) content 
GSH contents in the tissues of tumor-bearing 
control mice showed the highest level of GSH in the 
liver followed by kidney and DL cells. MeOH-
propolis treatment of tumor-bearing mice showed a 
slight increase in GSH level in the liver and kidney 
but caused a significant decrease in GSH level in DL 
cells. In the case of reference drug cisplatin, the 
significant decrease in GSH level was observed in 
kidney and DL cells (Table 2). 
 
 
Fig. 1 — Trypan blue exclusion viability evaluation of Dalton’s 
lymphoma (DL) cells and splenocytes from tumor-bearing mice. 
Control= DL cells treated with drug vehicle alone. A significant 
decrease in the viability of DL cells was observed after the 
methanol extract of propolis (MeOH-propolis) and cisplatin 
treatment. The results are expressed as mean±S.D., n=4. The 
significance of the changes between control and the treated group 
was tested by ANOVA, p ≤0.05. 
 
 
Fig. 2 — Changes in the bodyweight of tumor-bearing mice in 
different groups. Control= Ascites Dalton’s lymphoma bearing mice 
treated with drug vehicle alone. A decrease in the bodyweight of the 
hosts was observed after the methanol extract of propolis (MeOH-
propolis) and cisplatin treatment. The details of the treatment schedule 
are described in the methodology. The results are expressed as 
mean±S.D., n=4. The significance of the changes between control and 
the treated group was tested by ANOVA, p ≤0.05. 
Table 1 — Antitumor activity of MeOH-propolis and cisplatin against murine ascites Dalton’s lymphoma (DL) 
Treatment group Day of treatment Survival days (Mean±SD) ILS (%) 
Group- I (Control)  19.5±1.29  
Group- II (MeOH-propolis treatment,  
i.p, 50 mg/kg body weight/day) 
6th day post tumor transplantation 
(for 5 consecutive days ) 
38.5±1.0* 97.43 
Group- III (Cisplatin treatment,  
i.p, 2 mg/kg body weight/ day) 
6th day post tumor transplantation 
(for 5 consecutive days ) 
45.5±1.5* 133.34 
MeOH-propolis = Methanol extract of propolis; i.p. = intraperitoneal. ILS= Average increase in life span. Results are expressed as 
mean±S.D. The significance of changes between control and different treated groups was tested by one-way ANOVA, n= 4, *P ≤0.05 as 
compared to the control. Control= Tumor-bearing mice treated with extract vehicle only. 





As compared to tumor-bearing control, cisplatin 
treatment caused a decrease in the haemoglobin (Hb) 
content, RBC and WBC count. Propolis treated mice 
did not decrease the lymphocytes, haemoglobin 
concentration, RBC and WBC counts (Table 3, 4). As 
compared to a corresponding control, a decrease in 
the PCV was noted after cisplatin treatment. 
However, propolis treated mice showed a slight 
increase in PCV (Table 3) 
 
Morphological abnormalities in RBCs 
SEM revealed the development of various 
abnormalities in RBCs in tumor-bearing mice under 
different treatment conditions. Normocytes (having a 
smooth surface), are the normal erythrocytes which 
are normal in size and shape. Different morphological 
abnormalities in RBCs observed include the 
microcytes (cells having a smaller diameter than the 
normal erythrocytes), macrocytes (having larger 
diameter), echinocytes (presence of uniformly 
serrated projections), acanthocytes (spiculated or 
thorn-like cells), schistocytes (small fragmented 
spindle-shaped cells), spherocytes (sphere-shaped cell 
smaller than normal RBC), stomatocytes (elongated 
cells with the presence of slot-like structure at the 
centre), ovalocytes (having oval-shaped cells) and 
elliptocytes (having elliptical-shaped cells) (Fig. 3). 
Cisplatin treatment caused a significant increase in 
abnormalities in RBCs. However, in MeOH-propolis 
treated tumor-bearing mice abnormalities in the RBCs 
did not increase and it was quite comparable to that of 
control (Fig. 4). 
Table 2 — Changes in GSH content (µmol/g wet wt.)  
in the tissues of tumor-bearing mice under different  
treatment conditions 
Treatment group Liver Kidney DL cells 
Control 48 h 11.16 ±0.29 8.55±0.57 6.26±0.05 
96 h 10.66±0.52 8.29±0.63 6.405±0.12 
MeOH-propolis 48 h 10.56±0.10 8.22±0.31 3.98±0.26* 
96 h 10.49±0.14 8.79±0.69 4.37±0.09* 
Cisplatin 48 h 9.12±0.22* 6.44±0.43* 3.40±0.11* 
96 h 8.52±0.18* 6.12±0.28* 3.48±0.21* 
Control= Tissues from untreated tumor-bearing hosts receiving 
extract vehicle alone. The methanol extract of propolis (MeOH-
propolis) treatment caused a significant decrease in GSH content 
in DL cells while cisplatin decreased GSH in DL cells as well as 
in the liver and kidney. Results are expressed as mean±S.D. The 
significance of changes between treated and respective control 
was tested by one-way ANOVA, n= 4, *P ≤ 0.05 as compared to 
the control.  
Table 3 — Changes in the haematological values in tumor-bearing mice under different treatment conditions 
Treatment groups Hb (g/dL) RBC (x1012/l) WBC(x109/l) PCV (%) 
Normal 14.02±0.88 7.72±0.36 4.73±0.34 45.87±2.77 
Control 48 h 11.40±0.87 6.81±0.86 8.87±0.83 35.87±0.76 
96 h 9.97±0.71 6.74±0.67 10.86±0.48 31.87±0.31 
MeOH-propolis 48 h 11.97±0.73 7.22±0.60 7.45±0.47* 36.93±0.33 
96 h 13.08±0.98* 7.88±0.34* 9.04±0.60 37.96±0.44* 
Cisplatin 48 h 10.06±0.52 5.81±0.51 8.19±0.60 26.14±0.66* 
96 h 8.92±0.68* 6.35±0.95* 8.19±0.29* 30.93±0.46 
Normal= Mice without tumor or any treatment condition; Control= Untreated tumor-bearing mice; Hb= Haemoglobin; RBC= Red blood 
cells, WBC= White blood cells; PCV= Packed cell volume; Results are expressed as mean±S.D. ANOVA, n= 4, *p ≤0.05 as compared to 
the corresponding control. 
 
Table 4 — Differential leukocytes counts (mean % ± S.D.) in the blood of normal and tumor-bearing mice under different treatment 
conditions 
Treatment groups Lymphocytes Monocytes Neutrophils Eosinophils Basophils 
Normal 58.29±5.52 3.58±0.44 33.06±2.72 1.72±0.18 0.87±0.19 
Control (DL-bearing ) 48 h 26.92±0.31 2.30±0.17 67.85±1.91 3.28±0.21 1.15±0.03 
Control (DL-bearing ) 96 h 23.09±0.53 1.86±0.12 71.36±1.79 4.19±0.17 1.07±0.01 
MeOH-propolis- 48 h 31.05±0.50* 2.82±0.10 65.02±3.95 5.26±0.42* 0.64±0.02 
96 h 29.22±0.27* 2.38±0.11* 69.39±3.16 5.71±0.42* 0.81±0.12 
Cisplatin- 48 h 20.14±0.82 2.64±0.31 74.66±1.05 4.97±0.11 0.78±0.20 
96 h 18.19±0.55* 2.78±0.32* 77.89±0.39 5.63±0.40* 0.68±0.11 
Normal = Blood from the mice without tumor or treatment. Control = Blood from the tumor-bearing mice treated with extract vehicle 
only. DL = Dalton’s lymphoma; MeOH-propolis= Methanol extract of propolis treated tumor-bearing mice; Cisplatin = Cisplatin treated 
tumor-bearing mice. The details of the treatment schedule have been given in Materials methods. Results are expressed as mean ± S.D. 
One way ANOVA test, n= 4, *p ≤0.05 as compared to the corresponding control. 





Histopathological examination of kidney in control 
mice showed normal renal glomeruli and tubules 
having intact epithelial cells (Fig. 5a). However, 
cisplatin treatment of mice caused immense 
destruction of the renal tubular cells represented  
by glomerular atrophy, infiltration of cells and  
tubular congestions (Fig. 5b) which supports the  
view that cisplatin alone treatment caused 
nephrotoxicity and cellular damage in the host. 
However, MeOH-propolis treatment of mice showed 
no destruction of renal tubular cells and glomerular 
damage thereby signifying no nephrotoxicity in the 
hosts (Fig. 5c). 
Liver histology from control mice showed a  
normal arrangement of hepatocytes and proper  
central vein (Fig. 6a). In contrast, mice treated  
with cisplatin exhibited severe hepatotoxicity 
characterized by diffused sinusoidal distortion, 
congestion in the central vein and remarkable 
locational hepatocytes damage (Fig. 6b). However, 
MeOH-propolis treatment of mice showed no  




Fig. 3 — Representative scanning electron micrographs (SEM) showing normal RBCs N= Normocytes (a), and various types of 
abnormalities (arrows) in RBCs under different treatment conditions, Ma= Macrocytes, Mi= Microcytes (b), Ec= Echinocytes (c),  




Fig. 4 — The pattern of normal and abnormal shaped red blood 
cells (RBCs) in the blood of control and different treatment 
groups. The methanol extract of propolis (MeOH-propolis)  
did not alter the pattern of abnormalities in RBCs while  
cisplatin treatment caused a significant increase in abnormalities 
in RBCs. Results are expressed as mean±S.D., n=3. The 
significance of the changes was tested by ANOVA, *p ≤0.05  
as compared to control.  





Cisplatin treatment induced several abnormalities 
in sperms. The type/shape of sperm abnormalities 
induced by cisplatin included hookless head,  
looping mid-piece, balloon-like head, incorrect  
head-neck connection, diffused head, amorphous 
head, etc. (Table 5; Fig. 7). MeOH-propolis 
treatment showed very less frequency of sperm 




Fig. 5 — Histopathological features of the kidney from tumor-bearing mice under different treatment conditions. Histology of kidney 
control (a), Cisplatin (b), and MeOH-propolis treated mice (c). Regular arrows showing glomerulus and a dotted arrow showing the 




Fig. 6 — Histopathological features of liver from tumor-bearing mice under different treatment conditions. Control (a), CDDP (b), MeOH-




Fig. 7 — Representative photographs of various types of morphological abnormalities in sperms in Dalton’s lymphoma (DL) tumor-
bearing mice at different treatment conditions. (a) normal, (b) hookless, (c) balloon-like head,(d) looping mid-piece, (e) diffused head  
(f) incorrect head-neck connection, and (g) amorphous head. 
 
Table 5 — Quantitative analysis of various types of sperm abnormalities in the hosts under different treatment conditions 
Treatment No. of sperms 
observed 
No. of abnormal 
sperms 
HL LMP BH IHNC DH AH Mean % of abnormal 
sperm  ± S.D. 
Control 500 8 3 0 1 0 1 3 1.40±0.2 
MeOH-propolis treated 500 9 4 0 1 1 1 2 1.80±0.4* 
Cisplatin treated 500 37 13 3 4 2 3 12 7.4±0.5* 
Results are expressed as mean±S.D. One-way ANOVA, Tukey’s test, n=4, *p ≤0.05 as compared to control. HL=Hookless head, 
LMP=looping midpiece,  
BH=balloon like head, IHNC=incorrect head-neck connection, DH=diffused head, and AH=amorphous head. Sperm analysis was carried 
out on the 10th day of treatment condition 
 






Fig. 8 — Average per cent abnormal sperms in tumor-bearing 
mice at different treatment conditions. Cisplatin treatment caused 
a significant increase in abnormalities in sperms. Results are 
expressed as mean±S.D., n=3. The significance of the changes 





 and novel natural biodegradable 
approach developing nanoparticles
35
 have been used 
as promising sources for the discovery of new 
pharmaceutical agents. As a natural honeybee hive 
product, propolis extracts have been used as a 
remedial agent in traditional medicine. The 
composition and biological properties of propolis can 
vary depending on the bee species and trees and 
flowers they have access to
12,22
. The present study 
exhibits the findings on the assessment of anticancer 
activity and toxicity of methanolic extract of 
Meghalaya propolis (MeOH-propolis) in mice bearing 
Dalton’s lymphoma ascites tumor which has been 
frequently used in the evaluation of the anti-cancer 
activity of various drugs and extracts derived from 
plants and animals
6,36,37
. The MeOH-propolis 
treatment of tumor-bearing mice did not affect the 
viability of the splenocytes representing normal cells 
while the viability of Dalton’s lymphoma tumor cells 
was very much decreased (Fig. 1). This indicates that 
the MeOH-propolis has differential effects on normal 
cells and tumor cells. The cytoprotective role of 
propolis
38
 or its chemical constituent caffeic acid 
phenethyl ester (CAPE)
39
 has been reported. An 
increase in the survival time and changes in body 
weight has been used as a reliable parameter to assess 
the anticancer activity of drugs
36,37
. As compared to 
the untreated DL-bearing control mice, MeOH-
propolis treatment significantly prevented the increase 
in body weight (Fig. 2) indicating a reduction in 
tumor growth and resulted in increased mean survival 
time of the tumor-bearing mice (Table 1). Ethanol 
extract of Turkish propolis was reported to exhibit 
powerful cytotoxic effects against five human cancer 
cell lines
13
. The ethanolic extract of Moroccan 
propolis caused an effective reduction in the tumor 
volume in P815 tumor-bearing mice and apoptotic 
induction in P815 cells
40
. MeOH-propolis has also 
been reported to induce apoptosis in DL cells
27
. The 
reference anticancer drug cisplatin treatment also 
depicted a similar pattern of changes in the body 
weight and survival of the hosts thereby corroborating 
the potential anticancer activity of MeOH-propolis 
(Fig. 2; Table 1). 
Reduced glutathione (GSH), the tripeptide of  
L-γ-glutamyl-L-cysteinyl-glycine, is the most abundant 
antioxidant in the cells and plays a key role in 
maintaining intracellular redox equilibrium and in 
augmenting cellular defence to harmful factors
41
. 
GSH plays an important role in a multitude of  
cellular processes such as cell differentiation, 
proliferation, and apoptosis, and disturbances in GSH 
homeostasis are involved in the etiology and 
progression of many human diseases including 
cancer
42
. The modulation of the GSH-based 
antioxidant redox system has been suggested as a 
promising therapeutic strategy for overcoming cancer 
cell progression and drug resistance. A direct 
correlation between GSH levels and cellular 
proliferation, cancer metastatic activity as well as a 
decrease in the rate of cancer cell proliferation with a 
decrease in GSH level in cancer cells has been 
reported
43,44
. The MeOH-propolis treatment of tumor-
bearing mice caused a decrease in GSH levels in DL 
cells but not in the liver and kidney (Table 2). The 
decreased GSH levels may lead to the alterations in 
the antioxidant machinery accompanied by decreased 
proliferation/survival of DL cells. The reference drug, 
cisplatin treatment showed a decrease in GSH level in 
DL cells as well as in the liver and kidney (Table 2) 
which may be correlated with its cytotoxicity in DL 
cells and toxic effects in the liver and kidney of the 
hosts as has been observed being described later on. 
Cisplatin has been well established to cause 
hepatotoxicity and nephrotoxicity in the hosts
45
. On 
the other hand, the observation that MeOH-propolis 
treatment did not decrease GSH levels in the liver and  




kidney, may help to maintain normal structural  
and functional activity. 
Hematological and biochemical parameters are 
important tools that aid in the elucidation of 
pathological/toxicological problems. Haematological 
findings show that as compared to normal mice, a 
decrease in Hb content and RBCs count occurred in 
control tumor-bearing mice. Chemotherapy including 
cisplatin treatment has been reported to cause  
anaemia and decrease in RBC, Hb production
46
. 
Cisplatin-treated tumor-bearing mice showed a 
decrease in Hb content and RBCs count (Table 3). On 
the other hand, MeOH-propolis treated tumor-bearing 
mice showed a significant increase in Hb content, 
RBCs count, WBCs count and hematocrit (PCV) as 
compared to cisplatin-treated tumor-bearing mice 
(Table 3). Similar to this observation an elevation of 
total erythrocytes counts and haemoglobin was 
reported in Muscovy broiler ducks kept on ethanol 
extracted propolis
47
. Other reports showed that the 
administration of propolis to diabetic mice 
significantly elevated haematological parameters  
such as the total number of red blood cells, 
haemoglobin and hematocrit level
48
. Similarly, the 
observed MeOH-propolis-mediated increase in 
haemoglobin content, RBCs and WBCs count may 
suggest its stabilizing role on haematological 
parameters in tumor-bearing mice. Our findings are in 
agreement with the report showing the combined 
action of Egyptian propolis as antitumor and 
antibacterial as well as its ability to stabilize the 
haematological parameters in cancer-bearing mice 
and it was suggested the possibility of using  
propolis as a natural alternative to chemotherapy to 
avoid the side effects
49
. The inclusion of Brazilian 
propolis in the ration of Blue-fronted Amazons has 
been reported to improve the haemoglobin, 
eosinophils and serum biochemical parameters. It was 
suggested that the eosinophil values are increased by 
the immunomodulatory action of Brazilian propolis
23
. 
Leukocytosis is a pathological condition, usually 
happened due to the increased number of neutrophils 
and by affecting the WBCs that frequently rises after 
infection, chronic inflammation, and cancer. The 
presence of cancer itself can lead to the development 
of leukocytosis as a reaction against the neoplasm
50
. 
A similar observation was made here also with an 
increase in neutrophils, eosinophils, and basophils and 
decreased in lymphocytes and monocytes in control 
tumor-bearing mice (Table 4). Cisplatin treated 
tumor-bearing mice showed a decrease in basophils 
and neutrophils. MeOH- propolis treatment showed a 
significant increase in lymphocytes and eosinophils 
(Table 4). The present observation is supported by 
another finding which showed that the ethanolic 
extract of propolis improved or did not change 
various haematological parameters in BALB/c mice
51
. 
Decreased antioxidant capacity and increased  
fragility in RBC are supported by the observation of 
various types of cisplatin-induced morphological 
abnormalities in erythrocytes as observed in Scanning 
electron microscopy of RBCs (Fig. 3, 4). On the other 
hand, MeOH-propolis treated tumor-bearing mice 
showed decreased frequency of abnormalities in the 
RBCs as compared to that of cisplatin (Fig. 4)  
which may suggest that MeOH-propolis has minimal 
or no hematotoxicity. Exact mechanisms underlying 
propolis-mediated stabilization in haematological 
values are not known, however, it may be suggested 
that the observed improvement in haematological 
values may be involved in enhancing host immunity, 
thereby increasing host survivability. 
Along with haematological changes evaluation  
of histological images are the key ingredients in 
medical diagnosis and prognosis. Evaluation of 
histopathological changes is commonly used for 
detecting organ-specific effects related to chemical 
exposure
52
. The liver and kidney are important organs 
of metabolism, detoxification, storage and excretion 
of xenobiotics and their metabolites, and are 
especially vulnerable to damages. The evaluation of 
kidney and liver histopathological changes have 
played a crucial role in studying the toxicity effects  
of a drug
53,54
. Cisplatin-induced nephrotoxicity, 
recognized as the most important dose-limiting factor, 
has been suggested to be caused probably due to 
apoptosis, inflammatory mechanism, and generation 
of ROS
53
. In the present study, cisplatin caused the 
destruction of the renal tubular cells represented by 
glomerular atrophy, infiltration of cells and tubular 
congestions and destruction (Fig. 5). Cisplatin 
treatment developed severe hepatotoxicity causing 
diffused sinusoidal distortion, congestion in the 
central vein and remarkable locational hepatocytes 
damage (Fig. 6). Different studies have suggested  
that increased production of ROS and oxidative stress 
play an important role in cisplatin-induced liver 
damage resulting in a reduction in the mitochondrial 
membrane potential and a decrease in antioxidant 
enzymes
55
. The general architecture of the liver, the 




appearance of the hepatocytes, the hepatic sinusoids, 
portal triads, and central veins showed that MeOH-
propolis treatment develops no adverse effects in the 
hosts (Fig. 6). Other studies also observed that the 
ethanolic extract of propolis did not produce any toxic 
effect in BALB/c mice showing the normal 
histological architecture of the liver, spleen, kidney, 
and brain after propolis treatment
51
. 
Sperm abnormality (SA) analysis is considered 
feasible and reliable endpoints to identify chemicals 
that induce spermatogenic dysfunction. The 
abnormalities in sperm morphology have been 
suggested to be a consequence of mutagenic effects. 
Various reports have shown the cisplatin-induced 
reproductive toxicity in male rats and it is correlated 
with an increase in the thiobarbituric acid reactive 
substances (TBARS) and oxidative stress in testicular 
tissues, and change of the intra-testicular testosterone 
concentrations
56
. In the present study also sperm 
abnormality analysis showed that cisplatin-induced 
various types of sperm abnormalities in DL-bearing 
mice with amorphous head and hookless sperm 
occurring more frequently (Table 5; Fig. 7 & 8). 
However, in MeOH-propolis- treated tumor-bearing 
mice the frequency of various abnormalities in sperms 
was very low (Table 5; Fig. 8) which suggests that 
MeOH-propolis did not develop sperms related 
mutagenic effects in the hosts. Propolis has been 
reported to improve sperm characteristics of rabbit 
reproductive toxicity induced by an endocrine 
disruptor, trypheniltin
57
. It has also been shown that 
propolis ameliorates the toxicity on sperm quality  
and reproductive organs of cyclosporine-A, an 
immunosuppressive drug, possibly by scavenging the 
free radicals and increasing the antioxidant 
activities
58
. In present studies also the increasing 
antioxidant activities in the form of GSH levels were 
noted in the liver and kidney after MeOH-propolis 
treatment (Table 2) which may infer that the same 
thing should be happening in the testes also to involve 
similar mechanism to keep away any testicular 
toxicity in tumor-bearing hosts. It has been 
demonstrated that ethanol-extracted Brazilian green 
propolis did not induce significant histopathological 
changes in any organ, and further exerted anti-
inflammatory and antitumorigenic effects increasing 
the survival of Wistar Hannover rats
59
. MeOH-
propolis has also been found to exhibit antioxidant 
activity because of the presence of polyphenols  
such as flavonoids and phenolic acids
60
. The 
antioxidant activity of propolis has been reported  
to display these beneficial effects by suppressing  
the formation of free radicals to show various  
health-promoting useful effects. 
 
Conclusion 
In conclusion, the present findings demonstrate the 
combined action of the MeOH-propolis as an 
anticancer as well as its ability to stabilize various 
toxicity parameters in cancer-bearing mice. Thus, the 
possibility of using propolis as a natural alternative to 
chemotherapy to avoid the side effects and 
supplementation of the bee products including 
propolis in food should have important beneficial 
effects in the body.  
 
Conflict of interest 
The authors declare no potential conflict of  
interest concerning the authorship and/or publication 
of this article. 
 
Acknowledgement 
We would like to thank the people of  
Ngunraw village who had shared the essential 
information and sample collection. The financial 
support in the form of National Fellowship for  
Higher Education of Scheduled Tribe students,  
Govt. of India provided to I. Turina is duly 
acknowledged. We also thank the sophisticated 
analytical instrumentation facility (SAIF), NEHU, 
Shillong for SEM, and Department of Zoology, 
NEHU, Shillong for research facilities. 
 
References 
1 Cancer. World Health Organization. Available at: 
https://www.who.int/news-room/fact-sheets/detail/cancer. 
Accessed on 18 April 2019. 
2 McDonnell A M, 2016, Chemotherapeutic agents and  
their uses, dosages, and toxicities, Available at: 
http://www.cancernetwork.com/cancer-management/ 
chemotherapeutic-agents-and-their- uses-dosages-and-
toxicities. accessed on September 20, 2018.  
3 Siddik Z H, Cisplatin: mode of cytotoxic action and 
molecular basis of resistance, Oncogene, 2003, 22(47), 
7265-7279. 
4 Khazir J, Riley D L, Pilcher L A, De-Maayer P and Mir B A, 
Anticancer agents from diverse natural sources, Nat Prod 
Commun, 2014, 9(11), 1655-1669. 
5 Lichota A and Gwozdzinski K, Anticancer activity of natural 
compounds from plant and marine environment, Int J Mol 
Sci, 2018, 19(11), 3533-3570.  
6 Verma A K and Prasad S B, Changes in glutathione, 
oxidative stress and mitochondrial membrane potential in 
apoptosis involving the anticancer activity of cantharidin 




isolated from red-headed blister beetles, Epicauta hirticornis, 
Anti-Cancer Agents Med Chem, 2013, 13(7), 1096-1114. 
7 Wang L, Dong C, Li X, Han W and Su X, Anticancer 
potential of bioactive peptides from animal sources 
(Review), Oncol Rep, 2017, 38(2), 637-651. 
8 Honey bee. Available at: https://en.wikipedia.org/wiki/ 
Honey_bee, Accessed on 18 April 2019. 
9 Honey bees and their 7 wondrous products. Available at: 
https://www.benefits-of-honey.com/honey-bees.html, 
Accessed on 18 April 2019. 
10 Burdock G A, Review of the biological properties and 
toxicity of bee propolis (propolis), Food Chem Toxicol, 
1998, 36(4), 347-363. 
11 Anjum S I, Ullah A, Khan K A, Attaullah M, Khan H, et al., 
Composition and functional properties of propolis (bee glue): 
A review, Saudi J Biol Sci, 2019, 26(7): 1695–1703. 
12 Bankova V S, deCastro S L and Marcucci M C,  
Propolis: recent advances in chemistry and plant origin, 
Apidologie, 2000, 31(1), 3–15. 
13 Turan I, Demir S, Misir S, Kilinc K, Mentese A, et al., 
Cytotoxic effect of Turkish propolis on liver, colon, breast, 
cervix and prostate cancer cell lines, Trop J Pharm Res, 
2015, 14(5), 777-782. 
14 Silva-Carvalho R, Baltazar F and Almeida-Aguiar C, 
Propolis: A complex natural product with a plethora of 
biological activities that can be explored for drug 
development, Evid Based Complement Alternat Med, 2015, 
2015, 1-29. 
15 Kapare H, Lohidasan S, Sinnathambi A and Mahadik K, 
Standardization, anti-carcinogenic potential and biosafety of 
Indian propolis, J Ayurveda Integr Med, 2019, 10(2), 81-87. 
16 Sawicka D, Car H, Borawska M H and Nikliński J, The 
anticancer activity of propolis, Folia Histochem Cytobiol, 
2012, 50(1), 25–37. 
17 Ishida Y, Gao R, Shah N, Bhargava P, Furune T, et al., 
Anticancer activity in honeybee propolis: Functional insights 
to the role of caffeic acid phenethyl ester and its complex 
with γ-cyclodextrin, 2018, 17(3), 867-873. 
18 Shukla S, Bhadauria M and Jadon A, Evaluation of 
hepatoprotective potential of propolis extract in carbon 
tetrachloride induced liver injury in rats, Indian J Biochem 
Biophys, 2005, 42(5), 321-325. 
19 Babatunde I R, Abdulbasit A, Oladayo M I, Olasile O I, 
Olamide F R, et al., Hepatoprotective and 
pancreatoprotective properties of the ethanolic extract of 
Nigerian propolis, J Intercult Ethnopharmacol, 2015, 4(2), 
102-108. 
20 Ebeid S A, Abd El Moneim N A, El-Benhawy S A,  
Hussain N G and Hussain M I, Assessment of the 
radioprotective effect of propolis in breast cancer patients 
undergoing radiotherapy, New perspective for an old honey 
bee product, J Radiat Res Appl Sci, 2016, 9, 431-440. 
21 Aldahmash B A, El-Nagar D M and Ibrahim K E,  
Reno-protective effects of propolis on gentamicin-induced 
acute renal toxicity in Swiss albino mice, Nefrologia, 2016, 
36(6), 643-652. 
22 Toreti V C, Sato H H, Pastore G M and Park Y K, Recent 
progress of propolis for its biological and chemical 
compositions and its botanical origin, Evid Based 
Complement Alternat Med, 2013, 2013, 1-13. 
23 Silva C R, Putarov T C, Fruhvald E, Destro F C, Filho W C, 
et al., Action of Brazilian propolis on hematological and 
serum biochemical parameters of Blue-fronted Amazons 
(Amazona aestiva, Linnaeus, 1758) in captivity, 2014, 
Poultry Sci, 93, 1688–1694. 
24 Afrouzan H, Tahghighi A, Zakeri S and Es-haghi A, 
Chemical composition and antimicrobial activities of Iranian 
propolis, Iran Biomed J, 2018, 22(1), 50-65. 
25 Piccinelli A L, Mencherini T, Celano R, Mouhoubi Z, 
Tamendjari A, et al., Chemical composition and antioxidant 
activity of Algerian propolis, J Agric Food Chem, 2013, 
61(21), 5080-5088. 
26 Marak Q, People, societies and cultures in Meghalaya: A 
review of anthropological researches from the beginning to 
recent times, in Social Science Researches in North East 
India, edited by K. Jose and B. Das (Guwahati: DVS), 2017, 
288-312. 
27 Turnia I, Nongkhlaw F M W, Joshi S R and Prasad S B, 
Antibacterial and antitumor activity of methanolic extract of 
propolis from Meghalaya, World J Pharmacy Pharm Sci, 
2015, 4(11), 1809-1821. 
28 Goldie H and Felix M D, Growth characteristics of free 
tumor cells transformed serially in the peritoneal fluid of 
mouse, Cancer Res, 1951, 11, 173–180. 
29 Verma A K and Prasad S B, Changes in glutathione, 
oxidative stress and mitochondrial membrane potential in 
apoptosis involving the anticancer activity of  
Cantharidin isolated from Red-headed blister beetles, 
Epicauta hirticornis, Anti-Cancer Agents Med Chem,  
2013, 13, 
30 Strober W, Trypan blue exclusion test of cell viability, Curr 
Protoc Immunol, 1997, 21(1), A.3B.1-A.3B.2. 
31 Sedlak J and Lindsay R H, Estimation of total protein bound 
and non-protein sulfhydryl groups in tissue with Ellman’s 
reagent, Anal Biochem, 1968, 25, 192-205. 
32 Dacie J V and Lewis S M, Practical haematolgy, 5th edn 
(Churchill Livingstone, Edinburgh), 1975, 21-67. 
33 Swarup H, Pathak S C and Arora S, Laboratory techniques in 
modern biology (Kalyani publishers, New Delhi), 1981,  
163-186. 
34 Wyrobek A J and Bruce W R, Chemical induction of sperm 
abnormalities in mice, Proc Nat Acad Sci, 1975, 72(11), 
4425-4429. 
35 Ahmad N, Ahmad R, Alam M A, Ahmad F J, Amir M, et al., 
Daunorubicin oral bioavailability enhancement by surface 
coated natural biodegradable macromolecule chitosan based 
polymeric nanoparticles, Int J Biol Macromol, 2019, 128, 
825-838. 
36 Khynriam D and Prasad S B, Changes in endogenous tissue 
glutathione level in relation to murine ascites tumor growth 
and the anticancer activity of cisplatin, Braz J Med Biol Res, 
2003, 36(1), 53-63. 
37 Chockalingam V, Kadali S S and Gnanasambantham P, 
Antiproliferative and antioxidant activity of Aegle marmelos 
(Linn.) leaves in Dalton's lymphoma ascites transplanted 
mice, Indian J Pharmacol, 2012, 44(2), 225-229. 
38 Menyiy N E, Al-Waili N, Ghouizi A E, Al-Waili W and 
Lyoussi B, Evaluation of antiproteinuric and hepato-renal 
protective activities of propolis in paracetamol toxicity in 
rats, Nutrition Res Practice, 2018, 12(6), 535-540. 




39 Murtaza G, Karim S, Akram M R, Khan S A, Azhar S, et al., 
Caffeic acid phenethyl ester and therapeutic potentials, 
BioMed Res Int, 2014, 2014, 1-9. 
40 Mouse H A, Tilaoui M, Jaafari A, M’barek L A, Aboufatima 
R, et al., Evaluation of the in vitro and in vivo anticancer 
properties of Moroccan propolis extracts, Brazilian J 
Pharmacogn, 2012, 22(3), 558-567. 
41 Forman H J, Zhang H and Rinna A, Glutathione: Overview 
of its protective roles, measurement and, biosynthesis,  
Mol Aspects Med, 2009, 30, 1-12. 
42 Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro A L, 
et al., Role of glutathione in cancer progression and 
chemoresistance, Oxidat Med Cellular Longevity, 2013, 
2013, 1-10. 
43 Carretero J, Obrador E, Anasagasti M J, Martin J J, Vidal-
Vanaclocha F, et al., Growth- associated changes in 
glutathione content correlate with liver metastatic activity of 
B16 melanoma cells, Clinical Exp Metastasis, 1999, 17(7), 
567-574. 
44 Khynriam D and Prasad S B, Changes in endogenous tissue 
glutathione level in relation to murine ascites tumor growth 
and the anticancer activity of cisplatin, Braz J Med Biol Res, 
2003, 36, 53-63. 
45 Aldossary S A, Review on pharmacology of cisplatin: 
Clinical use, toxicity and mechanism of resistance of 
cisplatin, Biomed Pharmacol J, 2019, 12(1), 7-15. 
46 Bryer E and Henry D, Chemotherapy-induced anemia: 
Etiology, pathophysiology, and implications for 
contemporary practice, Int J Clinical Transfusion Med,  
2018, 6, 21-31. 
47 Abdel-Rahman M A and Mosaad G M, Effect of propolis as 
additive on some behavioural patterns, performance and 
blood parameters in Muscovy broiler ducks, J Advanced 
Veterinary Res, 2013, 3, 64-68. 
48 Oršolić N, Sirovina D, Končić M Z, Lacković G and 
Gregorović G, Effect of croatian propolis on diabetic 
nephropathy and liver toxicity in mice, BMC Complement 
Altern Med, 2012, 12, 117-131. 
49 Hegazi A G, Altahtawy R H M, Abdou A M and  
Allah F A, Egyptian propolis 10: it’s effect on  
hematological changes and bacterial load in mice-bearing 
ehrlich ascites carcinoma and concurrently infected with 
Staphylococcus aureus, Academic J Cancer Res, 2014, 7(3), 
215- 223. 
50 Yamaguchi S, Kanetaka K, Kobayashi S, Nagata Y,  
Kinosita N, et al., Severe neutrophilic leukocytosis as a 
progression marker in granulocyte colony‐stimulating 
factor‐producing squamous cell carcinoma of the esophagus, 
Clin Case Rep, 2017, 5(5), 688–693. 
51 Kalia P, Kumar N R and Harjai K, Studies on the effect of 
ethanolic extract of propolis in BALB/c mice, J Appl Nat Sci, 
2014, 6(2), 638-643. 
52 Crissman J W, Goodman D G, Hildebrandt P K, Maronpot R R, 
Prater D A, et al., Best practice guideline: Toxicologic 
pathology, Toxicol Pathol, 2004, 32, 126-131. 
53 Volarevic V, Djokovic B, Jankovic M G, Harrell C R, 
Fellabaum C, et al., Molecular mechanisms of cisplatin-induced 
nephrotoxicity: A balance on the knife edge, between 
renoprotection and tumor toxicity, J Biomed Science, 2019, 
26(1), 25-38. 
54 Loha M, Mulu A, Abay S M, Ergete W and Geleta B, Acute 
and subacute toxicity of methanol extract of Syzygium 
guineense leaves on the histology of the liver and kidney and 
biochemical compositions of blood in rats, Evidence-Based 
Complement Alternat Med, 2019, 2019, 1-15. 
55 Lu Y and Cederbaum A I, Cisplatin-induced hepatotoxicity 
is enhanced by elevated expression of cytochrome P450 2E1, 
Toxicol Sci, 2006, 89(2), 515-523. 
56 Jahan S, Munawar A, Razak S, Anam S, Ul Ain Q, et al., 
Ameliorative effects of rutin against cisplatin-induced 
reproductive toxicity in male rats, BMC Urol, 2018, 18,  
107-117. 
57 Yousef M I, Kamel K I, Hassan M S and El-Morsy A M, 
Protective role of propolis against reproductive toxicity of 
triphenyltin in male rabbits, Food Chem Toxicol, 2010, 
48(7), 1846-1852. 
58 Baykalir B G, Seven P T, Gur S and Seven I, The effects of 
propolis on sperm quality, reproductive organs and testicular 
antioxidant status of male rats treated with cyclosporine-A, 
Anim Reprod, 2016, 13(2), 105-111.  
59 Kakehashi A, Ishii N, Fujioka M, Doi K, Gi M, et al., 
Ethanol-extracted Brazilian propolis exerts protective effects 
on tumorigenesis in Wistar Hannover rats, PLoS One, 2016, 
11(7), 1-15. 
60 Turnia I, Prasad R and Prasad S B, GC-MS analysis of main 
chemical constituents and antioxidative potential of propolis 
from Meghalaya, India, J Global Pharma Technol, 2020, 
12(3), 1-11. 
 
 
 
